Jiangsu Hengrui Pharmaceuticals is planning to raise as much as US$1.27 billion via an initial public offering in Hong Kong, joining a wave of Chinese companies seeking to tap the city's market.

Hong Kong is calling for robotaxi operator Pony AI . The $6 billion Chinese company is exploring an offering in the city just ...

Jiangsu Hengrui Pharmaceuticals is planning to raise as much as US$1.27 billion via an initial public offering in Hong Kong, joining a wave of Chinese companies seeking to tap the city's market.

By Scott Murdoch (Reuters) -Chinese drug developer and producer Jiangsu Hengrui Pharmaceuticals is aiming to raise up to HK$9.89 billion ($1.27 billion) in a Hong Kong listing, according to a ...

Singapore-based medical testing firm Mirxes joins Jiangsu Hengrui Pharmaceuticals in revitalised market’s listing surge.

And another scoop: Two of FTI Consulting’s top economics experts in Europe have left to join Jonathan Orszag’s upstart rival ...

Chinese drug developer and producer Jiangsu Hengrui Pharmaceuticals is seeking to raise up to HK$9.89 billion ($1.27 billion) in a Hong Kong listing, according to a regulatory filing made on Thursday.

Pony.ai, which raised USD 413 million in a US IPO, is now planning a Hong Kong listing to fuel further expansion. The company operates 250 robotaxis and is developing mass production models with ...

Charming Medical, which provides therapies and products inspired by traditional Chinese medicine, filed for an initial public offering of 1.6 million shares. The company said in a filing with the ...

Pony AI Inc has confidentially filed for Hong Kong IPO to raise capital for expansion. Its stock surged and caught fire for ...

Chinese mining company Zijin Mining plans to spin off its gold business and list it on the Hong Kong stock exchange, with ...

This digital payment services provider is likely to get a lift from China's initiatives to boost domestic consumption.